Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Would be great if there was some good news like a ready willing and able partner to move some of the projects forward... Elto, MANF, Engineered Skin Cell... So much potential. We can only speculate at this point. Hoping for some news this week.
I've not detected any changes in fundamentals. Still an incredible risk-reward opportunity. Think this is likely just short-term traders getting involved which means we should cap out around .006, but these events always diversify the shareholder base which always tightens shares available, so big moves are possible.
I checked the Magna case. We are due for a ruling any day now, but nothing posted yet. If that ruling posts against Magna, that would be a game-changer for AMBS.
Hey Freegriff. What's your read on the recent uptick in SP here?
Anyone know what is behind the breakout?
$AMBS
what an opening Huge bids Huge loading we wont stay here for long IMO 0.0034 break small resistance and we can fly to the 02
Perhaps AMBS SP bump a leading indicator of success brewing at Todos. Pure speculation of course, IMHO.
moving here remember they own a big chunk 75M of TOMDF this wont stay down here
you guessed this prediction right
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169231750
$AMBS Huge support 005 coming?
les you are prolly 1 of the more level-headed AMBS posters around
however with all due respect, I simply can not see MANF gaining any substantive traction without the clout of having a BP with behind it - pushing essential next milestone deliverables...
its simply not going to happen in our lifetimes that way it is currently being studied and/or testing being conducted
AJMHO
Seems rats are getting all the benefits. Pretty soon the world will be inundated with them. LOL
Shareholders need:
Updates from CEO and acting CEO
Partnerships
Leadership
Is there a active board? What’s being done for shareholders? Minimum for a company that activitly trades and sale shares.
no need to point this out each time. When the dam breaks and we do enter human trials, I will be sure to make that fact clear as day. One foot in front of the other. Each one of these trials is a step in the journey.
More rat models....sigh
To clarify the impact of PRDX6 in hepatic fibrosis, we constructed a PRDX6 knockout (PRDX6-/-) rat model by using CRISPR/Cas9 method.
More new MANF research
MANF in hepatic fibrosis
https://www.sciencedirect.com/science/article/pii/S0753332222013208?via%3Dihub
No real application here, but interesting.
https://www.semanticscholar.org/paper/Hormonal-therapies-up-regulate-MANF-and-overcome-to-Zhang-Sun/643af4278b1a2789cb7833a5b23f85d914663d23
happened oct 17th too, big block sells. apparently no dilution. Could be a whale getting out over time. Could be a few fish getting out here and there. Stock recovers.
down today 38% on 5-Mil. share volume
Up nicely today on over 4M shares volume.
Waaaaaaaay more testing now than in 2008, each and every year the count and complexity grows, the publication count doesn't lie.
Fake news on the patents. Holding company owns these patents. I own a percent of the holding company, as do other investors.
more mice testing - been going on since 2008 and earlier
https://www.ahajournals.org/doi/full/10.1161/CIRCRESAHA.108.180679
besides all AMBS paid for Gerald to secure this patent - if he sells it, that cash goes into his pockets - not yours - not mine...!
oy vey
AJMHO
$AMBS Another MANF Gene Therapy Article from Cambridge/Sweden/Belgium: Will you own this stock when the dam breaks?
"Conclusions
The results from this study indicate gene delivery of AAV8.ins-Manf prevents the development of diabetes in experimental T1D. The findings further indicate that expression of MANF in pancreatic beta-cells may have protective functions for survival and proliferation of beta-cells."
https://pdfs.semanticscholar.org/a569/9a5c6fc5fc66a65e80e15c9ca68b36728fde.pdf?_ga=2.16546038.1754799164.1667030756-972150293.1625338335
good one...lolzzz
Bro has his family renting a modest 4bed 2 bath in an unimpressive suburb and does interviews in hoodies and the one good suit he bought 7 years ago.. You're telling lies about greed and theft.
What he did to shareholders? You mean never giving up? Any other CEO would have given up long ago, walked away, and there would be no chance of recovery. We still have a chance.
what GC did to AMBS shareholders should be criminal
unfortunately, the law may not side with the public in that regard
none-the-less, IMHO it still exemplifies one's severe lack of principals, morals and convictions - and just how low one will stoop for self-serving gratification...!
sorry if I ruffled your feathers - I did not compose that Tweet - however just look at AMBS's desecration & carnage left in Geralds "CEO" administrative wake...that's where the focus should be - and not on the messenger who delivers it...
32 CEO Blogs and not 1 of them was ever true - the experiment is over
"1 to 100 real fast" my arse
nuff said
JMHO
Surprise, surperise, surprise. Not
Note 9 – Subsequent Events On August 15, 2022, the Company received a notice from the Convertible Note Holders that the CRO VC had terminated discussions and was no longer interested in completing the transaction described in the Term Sheet. As a result, the Company and the Convertible Note Holders are currently negotiating a settlement of the convertible notes. On October 3, 2022, the Company received a termination notice from Psychogenics, Inc. with respect to the eltoprazine license agreement. The Company is currently evaluating its legal options.
Shareholders aren't paying for any of these studies and we're not paying him to answer this question. We have invested now knowing that the damn will eventually break and we will benefit if we're still standing.
yeah there's a lot of confusion as to just who exactly is running this SHIT SHOW
click on "VISIT WEBSITE" here:
https://www.linkedin.com/company/amarantus-biosciences/about/
now what's this link say about your soap bar buddy:
https://www.linkedin.com/company/amarantus-biosciences/people/
laughable - please try and keep up...!
Gerald is no longer the CEO of Amarantus. Shareholders should try to stay current on the facts.
how many mice studies does it take to get to a phase I clinical trial
[owl]
More MANF China research. in Septic Renal Injury and Colorectal Cancer. Gerald sharing a lot lately.
Conclusion: Mesencephalic astrocyte-derived neurotrophic factor has a certain protective effect on septic renal injury. Exogenous supplement of MANF can effectively alleviate the degree of renal injury after septic renal injury.
https://assets.researchsquare.com/files/rs-1886281/v1/d7812999-0217-4976-92b1-cc8118b50bc7.pdf?c=1663594677
More importantly, exogenous MANF significantly inhibited the migration of colon adenocarcinoma cells HCT116 and SW1116, but did not affect proliferation. Mechanistically, DLC1 reduced the retention of MANF in ER by competing the interaction between MANF and GRP78. Taken together, these data provided new insights into the suppressive effects of DLC1 on CRC, and revealed the potential of MANF in the treatment of CRC.
https://www.frontiersin.org/articles/10.3389/fonc.2022.900166/full
they been studying MANF in rats since 2012
and much earlier then that...!
https://academic.oup.com/ijnp/article/15/9/1343/671449
Gerald Commissiong CEO - what a pathetic joke....!!!
AJMHO
More MANF Research from China:
Increased serum concentrations of Mesencephalic astrocyte-derived neurotrophic factor in patients and rats with ischemic stroke
"MANF levels revealed a good value to diagnose TIA with area under the curve (AUC) of 0.949 (95% CI: 0.9093-0.9892)....Serum MANF levels correlate with neuroprotection, stroke severity, inflammation, and TIA recurrence."
J Stroke Cerebrovasc Dis
. 2022 Sep 7;31(11):106752. doi: 10.1016/j.jstrokecerebrovasdis.2022
The First Affiliated Hospital of Harbin Medical University
https://pubmed.ncbi.nlm.nih.gov/36087374/
Followers
|
651
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
130503
|
Created
|
07/14/11
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |